Aptevo Therapeutics Inc (APVO)
0.729
+0.02
(+2.53%)
USD |
NASDAQ |
May 28, 16:00
0.729
0.00 (0.00%)
After-Hours: 07:08
Aptevo Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.004M |
| June 30, 2022 | -0.025M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.118M |
| September 30, 2021 | -0.013M |
| June 30, 2021 | -0.391M |
| March 31, 2021 | -0.191M |
| December 31, 2020 | -0.088M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 28.12M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 4.25M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.153M |
| December 31, 2018 | 9.041M |
| September 30, 2018 | 27.95M |
| June 30, 2018 | 12.30M |
| March 31, 2018 | 23.51M |
| December 31, 2017 | -53.84M |
| September 30, 2017 | 65.36M |
| June 30, 2017 | 20.77M |
| March 31, 2017 | -2.83M |
| December 31, 2016 | 4.341M |
| September 30, 2016 | -49.76M |
| June 30, 2016 | -0.908M |
| March 31, 2016 | -1.071M |
| December 31, 2015 | -0.515M |
| September 30, 2015 | -0.438M |
| June 30, 2015 | -0.433M |
| March 31, 2015 | -0.141M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.391M
Minimum
Jun 2021
28.12M
Maximum
Mar 2020
1.577M
Average
--
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Heron Therapeutics Inc | 1.278M |
| Creative Medical Technology Holdings Inc | 6.520M |
| BioSig Technologies Inc | 0.00 |
| Adial Pharmaceuticals Inc | -- |
| IN8bio Inc | -0.071M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.651M |
| Cash from Financing (Quarterly) | -0.003M |
| Free Cash Flow | -22.95M |
| Free Cash Flow Per Share (Quarterly) | -9.685 |
| Free Cash Flow Yield | -8.06K% |